Nanalyze

Nanalyze
  • 3.5 (4)
  • INVESTING
  • UPDATED DAILY

Nanalyze is a media and research firm founded by finance professionals with decades of experience. We share insights about disruptive technology stocks in a language that is future-proof and easy to understand. Read all the Nanalyze Premium articles you'd like for free! Sign up for a 30-day trial of our monthly subscription with no strings attached: https://www.nanalyze.com/become-a-nanalyze-premium-subscriber/

  1. 4D AGO

    These 5 Canadian Dividend Monsters are CRUSHING IT

    The key factor for a dividend stock is its consistency. We look for predictability, favoring companies that not only have a long track record of paying dividends but also of increasing them. That's how we put together a list of sixteen Canadian dividend champions. In this video, we'll discuss five of them, and what makes them so great.Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/ahr3xFgBZBE.

    16 min

  2. 5D AGO

    Forget $NVDA. Memory Stocks Are EXPLODING in 2026!

    Sandisk stock is up over 1,500% since its spinoff from Western Digital thanks to an ongoing memory chip shortage. AI demand has caused memory suppliers to prioritize high-bandwidth memory, causing a shortage in all forms of memory out there. This increases prices, meaning memory stocks are all the rage right now, and electronics companies are bearing the weight of these higher input costs. Today we'll talk about three top stocks to play the memory chip boom: SK Hynix, Samsung, and Micron $MU. Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/cUiyhJ2FqdE.

    15 min

  3. FEB 10

    A $100 Billion Opportunity Just Getting Started

    The cure for cancer - at least today - is early detection. That's because if you can detect cancer soon enough, the chance for survival increases dramatically. We've identified two pure-play companies using blood tests for cancer detection, what's known as "liquid biopsy." Those companies are Guardant Health $GH and GRAIL $GRAL. Both offer a "multi-cancer" test, meaning you can screen for multiple cancers with a single blood sample. The market opportunity is measured in the hundreds of billions of dollars. Can these companies succeed where Theranos failed? Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/ARxnaI_L098.

    18 min

  4. FEB 7

    The Quickest Way to Destroy Your Portfolio

    Selling covered calls is easy money, right? Safe, reliable income? Wrong. Today we'll talk about five major mistakes most covered call sellers make while trying to earn passive income. You have to remember that there's no such thing as a free lunch, and if something sounds too good to be true, it probably is. Watch this video and make sure you don't get burned dabbling in covered call options. Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/o1C9z6MEbO8.

    15 min

  5. FEB 4

    Every Investor Should Invest in Canada

    Canada is the fourth largest investible developed market in the world, so every investor should have some exposure to it in their portfolio. How much of your portfolio should be in Canadian stocks? Which Canadian stocks should you hold? What about Canadian funds? We'll answer those questions and more in today's video on investing in Canada. Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/H9RCgOxtdSw.

    16 min

  6. JAN 31

    Are Software Stocks Being Eaten By AI?

    The market seems to think you should sell software stocks first and ask questions later. Large enterprise SaaS companies like Intuit $INTU, Salesforce $CRM, ServiceNow $NOW, and Adobe $ADBE are selling off like mad while the market hits new highs. The current narrative is that AI will destroy software. Who needs to pay for a CRM platform when you can just "vibe code" your own, right? Well, not exactly. As always, there is a lot of nuance here. Let's take a look at the five software stocks investors are most worried about. Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/b5M9Yml1ukg.

    17 min

  7. JAN 28

    HOT Data Center Energy IPO Happening!

    Forgent stock is getting ready to hit the market in a hotly anticipated IPO. The company has seen impressive revenue growth from their custom-made data center power solutions. Forgent is capitalizing on the data center boom, but is their stock a buy? Today, we'll look at how exactly Forgent makes money, and we'll uncover any red flags that came up in the company's S-1 filing document.Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/xXLkU4rXmkY.

    15 min

  8. JAN 24

    The Best Pharma Stock I’ve Ever Seen

    We don't invest in stories, but we can't deny United Therapeutics $UTHR has one of the coolest stories of any company we've analyzed. The founder of SiriusXM radio decided to create a pharmaceutical company to provide a cure for her daughter's life-threatening disease. Today, the company is worth over $20 billion with an annual run rate of nearly $1 billion. Talk about doing well while doing good.Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/SlJzadwsQIo.

    13 min
See All (409)

3.5
out of 5
4 Ratings

About

Nanalyze is a media and research firm founded by finance professionals with decades of experience. We share insights about disruptive technology stocks in a language that is future-proof and easy to understand. Read all the Nanalyze Premium articles you'd like for free! Sign up for a 30-day trial of our monthly subscription with no strings attached: https://www.nanalyze.com/become-a-nanalyze-premium-subscriber/

Information

  • Creator
    Nanalyze
  • Years Active
    2023 - 2026
  • Episodes
    409
  • Rating
    Clean
  • Copyright
    © Nanalyze
  • Show Website
    Nanalyze

You Might Also Like